Treatment of pigment dispersion syndrome.
Martin
X D
XD
D015237:Dinoprost / Q000627:therapeutic use; D004837:Epinephrine / Q000031:analogs & derivatives / Q000627:therapeutic use; D017889:Exfoliation Syndrome / Q000188:drug therapy*; D006801:Humans; D007498:Iris / Q000601:surgery; D053685:Laser Therapy; D008916:Miotics / Q000009:adverse effects; D012163:Retinal Detachment / Q000139:chemically induced
D008916:Miotics; C015173:dipivefrin; D015237:Dinoprost; D004837:Epinephrine